Our aforementioned results indicated that miR-106a-5p inhibited the cell migration and invasion and PAK5 was a direct target, next we discussed whether miR-106a-5p affected the cell migration and invasion of RCC cells via PAK5. Here, PAK5 is linked to renal cell carcinoma.